Synthetic biology improves productivity and resilience in bioprocesses, highlighting challenges in population control and regulatory hurdles.
Industrial microbiomes and synthetic microbial consortia are emerging as powerful tools for advancing sustainable bioprocesses. Unlike monocultures, these systems exploit natural microbial diversity and engineered interactions to enhance stability, resilience, and productivity. Applications include biofuel generation, waste valorization, pharmaceuticals, and environmental remediation. Advances in synthetic biology, systems biology, and computational modeling are driving the design of robust microbial communities tailored for industrial use. However, challenges such as population control, limited knowledge of microbial interactions, and regulatory hurdles remain. Addressing these issues will enable the development of next-generation microbiomes that are scalable, efficient, and environmentally sustainable.
No takes yet. Share an insight, caveat, or question.
Chukwudi Anthony Ugwuanyi (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: